(Press-News.org)
Memphis, Tennessee, April 4, 2023 – St. Jude Children’s Research Hospital has named Greg Armstrong, M.D., MSCE, the new chair of the Department of Epidemiology and Cancer Control, the department that has established the institution as a world leader in the study of childhood cancer survivorship.
A physician-scientist, Armstrong is the principal investigator of the Childhood Cancer Survivor Study (CCSS), a multi-institutional cohort and multidisciplinary collaborative resource for evaluating the long-term outcomes of children with cancer who survived five or more years after diagnosis. Continuously funded by the National Cancer Institute since 1994, the CCSS is the world’s largest established open resource for survivorship research. In addition, Armstrong is a co-program leader for the Cancer Control and Survivorship Program, one of the five major programs within the St. Jude Comprehensive Cancer Center.
“At St. Jude, we have a commitment to providing patients the best chances of survival and empowering them to lead healthy and fulfilling lives after treatment,” said James R. Downing, M.D., president and CEO of St. Jude. “Dr. Armstrong's leadership will be integral in achieving our mission to advance cures, and means of prevention, for pediatric catastrophic diseases.”
“Dr. Armstrong is not only a highly productive and impactful researcher, but also a passionate advocate for survivors,” said Charles W. M. Roberts, M.D., Ph.D., Executive Vice President and Director, Comprehensive Cancer Center. “He is an experienced leader who will bring outstanding capabilities to this key institutional leadership role.”
Armstrong assumes the position at a critical time for St. Jude as it continues to invest heavily in research to reduce the toxicity of cancer therapy and enhance the quality of life for all pediatric cancer survivors as part of the institution’s $12.9 billion strategic plan.
“The Department of Epidemiology and Cancer Control’s strong foundation will allow us to identify more effective and less toxic treatments to help long-term survivors and identify genetic predispositions to the long-term effects of common cancer treatments,” said Armstrong. “We want to disseminate this research globally so we can minimize the long-term side effects of pediatric cancer treatment.”
In addition to his duties at St. Jude, Armstrong is a member of the Children’s Oncology Group’s Scientific Council and Outcomes and Survivorship Committee and the Steering Committee for the NCI’s Childhood Cancer Data Initiative.
“I always knew I wanted to work in pediatrics and give children with cancer a chance to beat their enemy,” said Armstrong. “I have the two best jobs in the world as both a physician and a scientist: As an oncologist, I have the opportunity to take care of one patient and family at a time. However, it is through research on the long-term outcomes of these survivors that we have the opportunity to change care for an entire population.”
He earned his M.D. from the University of Alabama Medical School and his Master of Science in Clinical Epidemiology from the University of Pennsylvania. He completed his residency and fellowship training at The Children’s Hospital of Philadelphia.
Armstrong replaces the inaugural chair of the department, Les Robison, Ph.D., whose foundational work has been key in advancing some of the world’s largest and most impactful research programs in pediatric cancer survivorship.
St. Jude Media Relations Contacts
Chelsea Bryant
Desk: (901) 595-0564
Cell: (256) 244-2048
chelsea.bryant@stjude.org
media@stjude.org
Emily Gest
Desk: (901) 595-0260
Cell: (901) 568-9869
emily.gest@stjude.org
media@stjude.org
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer, sickle cell disease and other life-threatening disorders. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 60 years ago. St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. To learn more, visit stjude.org, read St. Jude Progress blog, and follow St. Jude on social media at @stjuderesearch.
END
About The Study: This study demonstrated that same-sex lesbian couples undergoing assisted reproductive technology (ART) had more favorable or similar birth outcomes to heterosexual couples who conceived naturally or underwent ART to conceive, suggesting that infertility-related factors rather than reproductive treatments contribute to higher rates of adverse birth outcomes in ART pregnancies.
Authors: Alice Goisis, Ph.D., of University College London, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2023.1345)
Editor’s ...
About The Study: Prenatal telehealth visits increased substantially during the early phase of the COVID-19 pandemic. The highest percentage of pregnancies with telehealth was observed in April 2020. Deliveries in November 2020 had the highest telehealth visit rates during the 40-week pregnancy.
Authors: Hari Eswaran, Ph.D., of the University of Arkansas for Medical Sciences in Little Rock, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi: 10.1001/jamanetworkopen.2023.6630)
Editor’s Note: Please see the article for additional ...
About The Study: The findings of this study of 12,000 older adults suggest that more social, cultural, and community engagement (SCCE) was associated with more dental and outpatient care utilization and reduced inpatient and community health care utilization. SCCE might be associated with shaping beneficial early and preventive health-seeking behaviors, facilitating health care decentralization and alleviating financial burden by optimizing health care utilization.
Authors: Daisy Fancourt, Ph.D., of University College London in London, is the corresponding author.
To access the embargoed study: Visit our ...
WASHINGTON — Submissions are now being accepted for the 2023 Eric and Wendy Schmidt Awards for Excellence in Science Communications, given by the National Academies of Sciences, Engineering, and Medicine in partnership with Schmidt Futures.
This application cycle marks the second year of the Eric and Wendy Schmidt Awards for Excellence in Science Communications which honor top science communicators, journalists, and research scientists who have developed creative, original work to communicate issues and advances in science, engineering, and/or medicine ...
Lifestyle behaviors such as eating well and exercising can be significant factors in one’s overall health. But the risk of developing cancer is predominantly at the whim of an individual’s genetics.
Our bodies are constantly making copies of our genes to produce new cells. However, there are occasional mistakes in those copies, a phenomenon geneticists call mutation. In some cases, these mistakes can alter proteins, fuse genes and change how much a gene gets copied, ultimately impacting a person’s risk of developing cancer. Scientists can better understand the impact of mutations by developing predictive models for tumor activity.
Christopher Plaisier, ...
Metal-organic frameworks (MOFs) have been gaining attention as promising carbon-neutral porous materials, thanks to their high performance in gas storage, separation, and conversion. The geometric building blocks of MOFs, metal clusters and organic linkers, allow chemists to predict and synthesize new structures like assembling LEGO®. However, finding new metal building blocks is still a daunting challenge due to the complex nature of metal ions in synthesis.
A research team, led by Professor Wonyoung Choe at Ulsan National Institute of Science and Technology (UNIST), South Korea, was inspired by the molecular metal clusters previously synthesized before ...
Chicago, April 4, 2023 — JAMA today announces the appointment of Atul Butte, M.D., Ph.D., to its editorial board.
An international leader in biomedical informatics, artificial intelligence, and data analytics for health care, Dr. Butte is the Priscilla Chan and Mark Zuckerberg Distinguished Professor at the University of California, San Francisco (UCSF) and inaugural Director of the Bakar Computational Health Sciences Institute at UCSF. He is also the Chief Data Scientist for the University of California Health System.
“I look forward to being an active contributor to the JAMA Editorial Board. I am excited by the new data and computational directions ...
The number of insects has been declining for years. This has already been well documented for agricultural areas. In forests, however, temporal trends are mostly studied for insect species that are considered pests. Now, a research team led by the Technical University Darmstadt have studied the trends of very many insect species in German forests. Contrary to what the researchers had suspected, the results showed: The majority of the studied species are declining. The results have been published in the scientific journal Communications ...
Results from a clinical trial conducted by researchers at the National Institutes of Health (NIH) show that people with low-grade lymphomatoid granulomatosis who are treated with interferon alfa-2b, a type of immunotherapy, can live for decades after diagnosis. Lymphomatoid granulomatosis is a rare precancerous condition triggered by Epstein-Barr virus infection. Left untreated, the disease can progress to a high-grade form, which has a poorer prognosis and can quickly turn into an aggressive and fatal B-cell lymphoma.
In the phase 2 trial, led by researchers in the Center ...
A team led by engineers at the University of California San Diego has developed a biodegradable polymer system to treat rheumatoid arthritis, an autoimmune and inflammatory disease, by working in concert with the power of the human immune system.
The research builds on increasing clinical interest in modulating the immune system to treat cancers and autoimmune disease, as well as previous work with all-trans retinoic acid (ATRA) which is produced naturally in the body and helps cells grow and develop. By approaching these challenges from the perspective of a biomaterials ...
